cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Syndax Pharmaceuticals
7 watching
Current Price
$26.57
$0.04
(0.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,597.46M
52-Week High
52-Week High
29.86
52-Week Low
52-Week Low
13.27
Average Volume
Average Volume
0.68M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,597.46M
icon52-Week High29.86
icon52-Week Low13.27
iconAverage Volume0.68M
iconDividend Yield--
iconP/E Ratio--
What does the Syndax Pharmaceuticals do?
Developing a therapy that enhances checkpoint immuno-oncology drugs.
Read More
How much money does Syndax Pharmaceuticals make?
News & Events about Syndax Pharmaceuticals.
Ticker Report
29days ago
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX Get Rating) has received an average recommendation of Moderate Buy from the seven ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have assigned...
PR Newswire
2 months ago
Syndax Announces Pricing of $150 Million Public Offering of Common Stock Syndax Announces Pricing of $150 Million Public Offering of Common Stock PR Newswire WALTHAM, Mass., Dec. 6, 2022 WALTHAM, Mass., Dec. 6, 2022 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ('Syndax,' the...
PR Newswire
2 months ago
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer PR Newswire WALTHAM, Mass., Dec. 2, 2022 WALTHAM, Mass., Dec. 2, 2022 /PRNewswire/ --Syndax Pharmaceuticals, Inc. (Nasdaq...
Ticker Report
3 months ago
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX Get Rating) have received a consensus rating of Moderate Buy from the six analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and ...
Zolmax
4 months ago
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX Get Rating) CEO Michael A. Metzger sold 29,606 shares of the companys stock in a transaction dated Friday, September 30th. The shares were sold at an average price of $25.02, for a total transaction of $740,742.12. Following the sale, the chief executive ...
Frequently Asked Questions
Frequently Asked Questions
What is Syndax Pharmaceuticals share price today?
plus_minus_icon
Can Indians buy Syndax Pharmaceuticals shares?
plus_minus_icon
How can I buy Syndax Pharmaceuticals shares from India?
plus_minus_icon
Can Fractional shares of Syndax Pharmaceuticals be purchased?
plus_minus_icon
What are the documents required to start investing in Syndax Pharmaceuticals stocks?
plus_minus_icon
What is today’s traded volume of Syndax Pharmaceuticals?
plus_minus_icon
What is today’s market capitalisation of Syndax Pharmaceuticals?
plus_minus_icon
What is the 52-Week High and Low Range of Syndax Pharmaceuticals?
plus_minus_icon
What percentage is Syndax Pharmaceuticals down from its 52-Week High?
plus_minus_icon
What percentage is Syndax Pharmaceuticals up from its 52-Week Low?
plus_minus_icon
Current Price
$26.57
$0.04
(0.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00